Ligand id: 7534

Name: eteplirsen

Structure and Physico-chemical Properties

2D Structure
Compound class Synthetic organic
Approved drug? Yes (FDA (2016))
International Nonproprietary Names
INN number INN
9339 eteplirsen
AVI-4658 | Exondys 51®
Eteplirsen is a novel oligonucleotide drug for the treatment of Duchenne muscular dystrophy (DMD), caused by specific reading frame mutations in the dystrophin gene [2]. Structurally it is a 30 base morpholino antisense oligomer in which a six-membered morpholine ring replaces the ribose sugars, and a phosphorodiamidate group replaces the normal anionic phosphodiester links between bases. This type of nucleotide is sometimes referred to as a phosphorodiamidate morpholino oligo, or PMO. While the size of this causes molecular indexing and rendering problems two images of the chemical structure were found. The first from the NIH US National Library of Medicine and they provide the InChIKey KZOVCSBYYXUVDW-UHFFFAOYSA-N. The second is ChemSpider 34983391 with a different InChIKey GHBMWAGCLOEKQK-BMBJILFMSA-N
Database Links
ChEMBL Ligand CHEMBL2108278
GtoPdb PubChem SID 187051835
Search PubMed clinical trials eteplirsen
Search PubMed titles eteplirsen
Search PubMed titles/abstracts eteplirsen
Wikipedia Eteplirsen